Key facts for NCD 130.3
- Benefit category
- Outpatient Hospital Services Incident to a Physician's Service
- Effective date
- Longstanding NCD
- Date of this version not posted by CMS
- Transmittal
- n/a
- Versions published
- 1
TL;DR
NCD 130.3 sets Medicare's national policy for chemical aversion therapy for treatment of alcoholism under the benefit category "Outpatient Hospital Services Incident to a Physician's Service", as a longstanding NCD (CMS has not posted the effective date of its current version). Available evidence indicates that chemical aversion therapy may be an effective component of certain alcoholism treatment programs, particularly as part of multi-modality treatment programs which include other behavioral techniques and therapies, such… It has been revised once since publication and binds every Medicare Administrative Contractor nationally.
Item or service described
Chemical aversion therapy is a behavior modification technique that is used in the treatment of alcoholism. Chemical aversion therapy facilitates alcohol abstinence through the development of conditioned aversions to the taste, smell, and sight of alcohol beverages. This is accomplished by repeatedly pairing alcohol with unpleasant symptoms (e.g., nausea) which have been induced by one of several chemical agents. While a number of drugs have been employed in chemical aversion therapy, the three most commonly used are emetine, apomorphine, and lithium. None of the drugs being used, however, have yet been approved by the Food and Drug Administration specifically for use in chemical aversion therapy for alcoholism. Accordingly, when these drugs are being employed in conjunction with this therapy, patients undergoing this treatment need to be kept under medical observation.
Indications and limitations of coverage
Available evidence indicates that chemical aversion therapy may be an effective component of certain alcoholism treatment programs, particularly as part of multi-modality treatment programs which include other behavioral techniques and therapies, such as psychotherapy. Based on this evidence, the Centers for Medicare & Medicaid Services’ medical consultants have recommended that chemical aversion therapy be covered under Medicare. However, since chemical aversion therapy is a demanding therapy which may not be appropriate for all Medicare beneficiaries needing treatment for alcoholism, a physician should certify to the appropriateness of chemical aversion therapy in the individual case. Therefore, if chemical aversion therapy for treatment of alcoholism is determined to be reasonable and necessary for an individual patient, it is covered under Medicare.
When it is medically necessary for a patient to receive chemical aversion therapy as a hospital inpatient, coverage for care in that setting is available. (See §130.1 regarding coverage of multi-modality treatment programs.) Follow-up treatments for chemical aversion therapy can generally be provided on an outpatient basis. Thus, where a patient is admitted as an inpatient for receipt of chemical aversion therapy, there must be documentation by the physician of the need in the individual case for the inpatient hospital admission.
Decisions regarding reasonableness and necessity of treatment and the need for an inpatient hospital level of care should be made by A/MACs based on accepted medical practice with the advice of their medical consultant. (In hospitals under Quality Improvement Organization (QIO) review, QIO determinations of medical necessity of services and appropriateness of the level of care at which services are provided are binding on A/MACs for purposes of adjudicating claims for payment.)
Text reproduced from the CMS Medicare Coverage Database record for NCD 130.3 version 1. View the original on cms.gov.
Local policies that build on this NCD
4 active Local Coverage Determinations cite NCD 130.3 among their related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.
- LCD L33624: Psychiatric Inpatient Hospitalization · Wellpoint Federal
- Outpatient Psychiatry and Psychology Services, LCD L34353 · CGS Administrators, LLC
- L34183 Psychiatric Inpatient Hospitalization · CGS Administrators, LLC
- L34570 Psychiatric Inpatient Hospitalization · Palmetto GBA
How MACs bill NCD 130.3
A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 3 current articles in the Medicare Coverage Database name NCD 130.3, 3 of them with a covered ICD-10-CM list, from 2 contractors. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.
| Contractor | Articles |
|---|---|
| CGS Administrators, LLC | A57052, A57065 |
| Wellpoint Federal | A56865 |
A56865: Billing and Coding: Psychiatric Inpatient Hospitalization
Billing and Coding, effective 2026-10-01 · Wellpoint Federal (06101, 06102, 06201, 06202, 06301, 06302, 13101, 13102, 13201, 13202, 13282, 13292, 14111, 14112, 14211, 14212, 14311, 14312, 14411, 14412, 14511, 14512) · CMS record
323 covered ICD-10-CM codes, 129 non-covered. Local policy: L33624 Psychiatric Inpatient Hospitalization.
First covered codes: F01.511 Vascular dementia, unspecified severity, with agitation; F01.518 Vascular dementia, unspecified severity, with other behavioral disturbance; F01.52 Vascular dementia, unspecified severity, with psychotic disturbance; F01.53 Vascular dementia, unspecified severity, with mood disturbance; F01.54 Vascular dementia, unspecified severity, with anxiety; F01.A0 Vascular dementia, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety; …
A57052: Billing and Coding: Psychiatric Inpatient Hospitalization
Billing and Coding, effective 2026-03-26 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record
422 covered ICD-10-CM codes. Local policy: L34183 Psychiatric Inpatient Hospitalization.
First covered codes: F01.50 Vascular dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety; F01.511 Vascular dementia, unspecified severity, with agitation; F01.518 Vascular dementia, unspecified severity, with other behavioral disturbance; F01.52 Vascular dementia, unspecified severity, with psychotic disturbance; F01.53 Vascular dementia, unspecified severity, with mood disturbance; F01.54 Vascular dementia, unspecified severity, with anxiety; …
A57065: Billing and Coding: Outpatient Psychiatry and Psychology Services
Billing and Coding, effective 2026-06-04 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record
772 covered ICD-10-CM codes in 5 groups; 38 procedure codes: 90785, 90791, 90792, 90832, 90833, 90834, 90836, 90837, 90838, 90839, 90840, 90845 and 26 more. Local policy: L34353 Outpatient Psychiatry and Psychology Services. Check a diagnosis for 90785.
First covered codes: F01.50 Vascular dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety; F01.511 Vascular dementia, unspecified severity, with agitation; F01.518 Vascular dementia, unspecified severity, with other behavioral disturbance; F01.52 Vascular dementia, unspecified severity, with psychotic disturbance; F01.53 Vascular dementia, unspecified severity, with mood disturbance; F01.54 Vascular dementia, unspecified severity, with anxiety; …
How this NCD shows up on remittances
A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.
For teams evaluating QuickIntell software
Evaluate a coverage-review workflow around NCD 130.3
Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions — NCD 130.3
What does NCD 130.3 cover?
Available evidence indicates that chemical aversion therapy may be an effective component of certain alcoholism treatment programs, particularly as part of multi-modality treatment programs which include other behavioral techniques and therapies, such as psychotherapy. Based on this evidence, the Centers for Medicare & Medicaid Services’ medical consultants have recommended that chemical aversion therapy be covered… The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.
When did NCD 130.3 take effect?
NCD 130.3 is a longstanding NCD (CMS has not posted the effective date of its current version); the current version is 1. This is the only published version.
Does a Local Coverage Determination override NCD 130.3?
No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Coverage Database NCDs via the CMS Coverage APIVersion API snapshot 2026-09-27 · effective 2026-09-20 · file national-coverage-ncd.jsonSHA-256 a90fadfd264b9ef4…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
Disclaimer
This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.